Rafael Castillo

Universidad Complutense de Madrid

H-index: 14

Europe-Spain

About Rafael Castillo

Rafael Castillo, With an exceptional h-index of 14 and a recent h-index of 11 (since 2020), a distinguished researcher at Universidad Complutense de Madrid, specializes in the field of Chemical synthesis, Nanotechnology, Medicinal chemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

Superparamagnetic iron oxide nanoparticles decorated mesoporous silica nanosystem for combined antibiofilm therapy

Delivery of Therapeutic Biopolymers Employing Silica-Based Nanosystems

Recent advances toward the use of mesoporous silica nanoparticles for the treatment of bacterial infections

Emerging Strategies in Anticancer Combination Therapy Employing Silica‐Based Nanosystems

Production of MCM-41 Nanoparticles with Control of Particle Size and Structural Properties: Optimizing Operational Conditions during Scale-Up

Mesoporous silica nanoparticles as carriers for therapeutic biomolecules

Rafael Castillo Information

University	Universidad Complutense de Madrid
Position	CIBER Postdoctoral researcher. Relocated to
Citations(all)	923
Citations(since 2020)	708
Cited By	471
hIndex(all)	14
hIndex(since 2020)	11
i10Index(all)	18
i10Index(since 2020)	11
Email	Access Email
University Profile Page	Universidad Complutense de Madrid
Google Scholar	View Google Scholar Profile

Rafael Castillo Skills & Research Interests

Chemical synthesis

Nanotechnology

Medicinal chemistry

Top articles of Rafael Castillo

Title	Author(s)	Publication Date
Superparamagnetic iron oxide nanoparticles decorated mesoporous silica nanosystem for combined antibiofilm therapy	Elena Álvarez Corchado Manuel Estévez Amado Álvaro Gallo Cordova Blanca González Ortiz Rafael R Castillo ...	2023/2/7
Delivery of Therapeutic Biopolymers Employing Silica-Based Nanosystems	Zoila Gándara Noelia Rubio Rafael R Castillo	2023/1/20
Recent advances toward the use of mesoporous silica nanoparticles for the treatment of bacterial infections	Rafael Castillo Romero María Vallet Regí	2021/6/30
Emerging Strategies in Anticancer Combination Therapy Employing Silica‐Based Nanosystems	Rafael Castillo Romero María Vallet Regí	2020/10/20
Production of MCM-41 Nanoparticles with Control of Particle Size and Structural Properties: Optimizing Operational Conditions during Scale-Up	Rafael Castillo Romero Lorena de la Torre Félix García Ochoa Miguel Ladero Galán María Vallet Regí	2020/10/24
Mesoporous silica nanoparticles as carriers for therapeutic biomolecules	Rafael R Castillo Daniel Lozano María Vallet-Regí	2020/5